Page 17 - Development Command News Today

Army researchers have developed the Personal Heating Dexterity Device, or PHD2, to help prevent the loss of hand function in the cold.

Comment: In light of the 'COVID-19 pandemic', which - despite its mortality rate being blown up out of all proportion to reality - is, nevertheless, indeed an illness stemming from infection by the SARS-CoV-2 virus first discovered by the Chinese...

MediWound Awarded a U.S. Department of Defense Research Grant for the Development of NexoBrid for the U.S. Army - read this article along with other careers information, tips and advice on BioSpace

Currently, 10 members of the Myanmar military—including two senior officers—are receiving practical security training in the country.

The vaccine developed at the Walter Reed Army Institute should not be privatized for maximum profit.

For decades, the University of Kentucky’s Gatton College of Business and Economics has conducted and published cutting-edge research in the rapidly expanding field of social network analysis. Now, UK, the University of Massachusetts Amherst and the U.S. Department of Defense (DoD) is announcing a $1.8 million collaboration aimed at improving retention and performance of military personnel.

All this begs the question: why does the Japanese government continue to train the Myanmar military? The Tatmadaw, along with other Myanmar security forces, has since the coup killed more than 1,400 people, detained over 10,000, and intensified abusive military operations in ethnic minority areas.

Across the country, the organizations are relieving stressed-out critical care teams and filling in where necessary to fight COVID-19. The telehealth system is ready for other disasters, as well.

A series of recently published preclinical study results show that the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at

J .Edward Derenberger Jr. (Boz) of La Plata, Md. passed away December 10, 2021 at the age of 93. He was born January 5, 1928...Click for more.